Autonomix Medical (NASDAQ:AMIX) Posts Quarterly Earnings Results, Beats Expectations By $1.38 EPS

Autonomix Medical (NASDAQ:AMIX) released its earnings results on Wednesday. The company reported ($5.02) earnings per share for the quarter, beating the consensus estimate of ($6.40) by $1.38, FiscalAI reports.

Autonomix Medical Stock Down 9.7%

Autonomix Medical stock traded down $0.73 during trading on Thursday, hitting $6.80. The stock had a trading volume of 212,932 shares, compared to its average volume of 1,562,243. Autonomix Medical has a 1 year low of $2.44 and a 1 year high of $32.55. The stock’s 50 day moving average is $6.86 and its two-hundred day moving average is $7.76. The stock has a market cap of $6.60 million, a price-to-earnings ratio of -0.09 and a beta of -1.17.

Analyst Ratings Changes

Several research firms have commented on AMIX. Weiss Ratings upgraded shares of Autonomix Medical from a “sell (e)” rating to a “sell (e+)” rating in a report on Tuesday, July 28th. Zacks Research upgraded shares of Autonomix Medical to a “hold” rating in a report on Tuesday, June 2nd. One research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Autonomix Medical presently has a consensus rating of “Hold” and an average target price of $42.00.

About Autonomix Medical

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.